Viewing Study NCT01699061


Ignite Creation Date: 2025-12-24 @ 11:53 AM
Ignite Modification Date: 2026-01-03 @ 8:45 AM
Study NCT ID: NCT01699061
Status: COMPLETED
Last Update Posted: 2019-02-12
First Post: 2012-10-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Tivantinib on the QTC Interval in Cancer Subjects
Sponsor: Daiichi Sankyo
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module